Evaluation of the hypothalamic-pituitary-adrenocortical axis in chronic leukaemia.
D015065:17-Hydroxycorticosteroids / Q000378:metabolism; D015068:17-Ketosteroids / Q000378:metabolism / Q000652:urine; D000305:Adrenal Cortex Hormones / Q000378:metabolism / Q000652:urine; D000328:Adult; D000368:Aged; D002066:Busulfan / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D002940:Circadian Rhythm; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000503:physiopathology*; D007951:Leukemia, Myeloid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D010913:Pituitary-Adrenal System / Q000503:physiopathology*
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D002699:Chlorambucil; D003520:Cyclophosphamide; D002066:Busulfan